Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19

Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19

BackgroundAlthough children with COVID-19 account for fewer hospitalizations than adults, many develop severe disease requiring intensive care treatment. Critical illness due to COVID-19 has been associated with lymphopenia and functional immune suppression. Myeloid-derived suppressor cells (MDSCs)...

Full description

Bibliographic Details
Main Authors: Katherine Bline, Angel Andrews, Melissa Moore-Clingenpeel, Sara Mertz, Fang Ye, Victoria Best, Rouba Sayegh, Cristina Tomatis-Souverbielle, Ana M. Quintero, Zachary Maynard, Rebecca Glowinski, Asuncion Mejias, Octavio Ramilo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Pediatrics
Subjects:
myeloid-derived suppressor cell (MDSC)
pediatric
COVID-19
respiratory disease
T cell
immune function
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2022.893045/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2022.893045/full

Similar Items